Abstract
The persistent infection with most frequent high-risk (HR)-HPV types (HPV-16, -18, -31, -33, -45, -52, and -58) is considered to be the true precursor of neoplastic progression. HR-HPV detection and genotyping is the most effective and accurate approach in screening of the early cervical lesions and cervical cancer, although also the HR-HPV DNA load is considered an ancillary marker for persistent HPV infection.
Here, it is described an in-house multiplex quantitative real-time PCR (qPCR)-based typing system for the rapid detection and quantitation of the most common HR-HPV genotypes from cervical cytology screening tests.
First, a separate qPCR assay to quantify a single-copy gene is recommended prior to screening (prescreening assay) to verify the adequate cellularity of the sample and the quality of DNA extracted and to normalize the HPV copy number per genomic DNA equivalent in the sample. Subsequently, to minimize the number of reactions, two multiplex qPCR assays (first line screening) are performed to detect and quantify HPV-16, -18, -31, -33, -45, -52, and -58 (HPV-18 and -45 are measured together by single-fluorophore). In addition, a multiplex qPCR assay specific for HPV-18 and HPV-45 is also available to type precisely the samples found to be positive for one of the two strains. Finally, two nucleic acid extraction methods are proposed by using a 96-well plate format: one manual method (supported by centrifuge or by vacuum) and one automated method integrated into a robotic liquid handler workstation to minimize material and hands-on time.
In conclusion, this system provides a reliable high-throughput method for the rapid detection and quantitation of HR-HPV DNA load in cervical samples.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2:342–350
Ho GY, Bierman R, Beardsley L et al (1998) Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338:423–428
Woodman CBJ, Collins SI, Young LS (2007) The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 7:11–22
Bosch FX, Muñoz N (2002) The viral etiology of cervical cancer. Virus Res 89:183–190
Bosch FX, Lorincz A, Muñoz N et al (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55: 244–265
Muñoz N, Bosch FX, De Sanjose S et al (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518–527
Wallin KL, Wiklund F, Angström T et al (1999) Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 341:1633–1638
Kjaer SK, van den Brule AJ, Paull G et al (2002) Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 325:572
Massad LS, Einstein MH, Huh WK et al (2013) 2012 Updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. 2012 ASCCP consensus guidelines conference. Obstet Gynecol 121:829–846
Massad LS, Einstein MH, Huh WK et al (2013) 2012 Updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. 2012 ASCCP consensus guidelines conference. J Low Genit Tract Dis 17:S1–S27
Dalstein V, Riethmuller D, Pretet JL et al (2003) Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer 106:396–403
Flores R, Papenfuss M, Klimecki WT et al (2006) Cross-sectional analysis of oncogenic HPV viral load and cervical intraepithelial neoplasia. Int J Cancer 118:1187–1193
Gravitt PE, Burk RD, Lorincz A et al (2003) A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiol Biomarkers Prev 12:477–484
Josefsson AM, Magnusson PK, Ylitalo N et al (2000) Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case–control study. Lancet 355:2189–2193
Lorincz AT, Castle PE, Sherman ME et al (2002) Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 360:228–229
Moberg M, Gustavsson I, Wilander E et al (2005) High viral loads of human papillomavirus predict risk of invasive cervical carcinoma. Br J Cancer 92:891–894
Broccolo F, Fusetti L, Ceccherini-Nelli L (2012) Is it true that pre-conization high-risk HPV DNA load is a significant factor of persistence of HPV infection after conization? J Clin Virol 55:377–378
Malnati MS, Scarlatti G, Gatto F et al (2008) A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load. Nat Protoc 3:1240–1248
Broccolo F, Cocuzza CE (2008) Automated extraction and quantitation of oncogenic HPV genotypes from cervical samples by a real-time PCR-based system. J Virol Methods 148:48–57
Broccolo F, Chiari S, Piana A et al (2009) Prevalence and viral load of oncogenic human papillomavirus types associated with cervical carcinoma in a population of North Italy. J Med Virol 81:278–287
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Broccolo, F. (2014). A Multiplex Real-Time PCR-Platform Integrated into Automated Extraction Method for the Rapid Detection and Measurement of Oncogenic HPV Type-Specific Viral DNA Load from Cervical Samples. In: Biassoni, R., Raso, A. (eds) Quantitative Real-Time PCR. Methods in Molecular Biology, vol 1160. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0733-5_8
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0733-5_8
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-0732-8
Online ISBN: 978-1-4939-0733-5
eBook Packages: Springer Protocols